SAN DIEGO — The FDA faces substantial pressure from patients and their families that can lead it to make questionable decisions, causing moral distress among physicians, according to a speaker at the ACP Internal Medicine Meeting.During his presentation, Kenneth Prager, MD, FACP, a professor of clinical medicine at Columbia University Medical Center, gave the example of the approval of